Company intelligence / Profile preview

Inagene Diagnostics

Toronto, Ontario, Canada

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Inagene Diagnostics provides pharmacogenetic testing to personalize medication choices, minimize side effects, and optimize outcomes for conditions such as pain, mental health, cardiovascular diseases, and women's health. Their tests are commercial and available to Canadian consumers and healthcare providers. Reports claim that 76% of tested patients received recommendations for medication changes by healthcare providers as a result of the tests[2].

Therapeutic areas: Women's HealthCardiovascularNeurologyPsychiatry
Industry: Molecular Diagnostics

Partnerships

The Newly InstituteGranville Biomedical Inc.Nurse Practitioners' Association of OntarioNutrigenomix

Beyond the preview

Go deeper on Inagene Diagnostics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inagene Diagnostics.

Explore the full profile